MedPath

Fensolvi

These highlights do not include all the information needed to use FENSOLVI safely and effectively. See full prescribing information for FENSOLVI.

Approved
Approval ID

dfb6e01c-f138-471d-bf5b-2be38247e3f0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 28, 2022

Manufacturers
FDA

TOLMAR Inc.

DUNS: 791156578

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Leuprolide Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62935-153
Application NumberNDA213150
Product Classification
M
Marketing Category
C73594
G
Generic Name
Leuprolide Acetate
Product Specifications
Effective DateDecember 5, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fensolvi - FDA Drug Approval Details